Search results for " Recurrence"

showing 10 items of 534 documents

Totally laparoscopic liver resections for primary and metastatic cancer in the elderly: safety, feasibility and short-term outcomes.

2012

Standard oncologic liver resections performed on elderly patients (≥70 years old) have been shown to be safe and effective. The aim of this study was to analyze operative and oncologic short-term outcomes of totally laparoscopic liver resections (TLLR) performed on elderly patients for malignancies. We performed a retrospective statistical analysis of prospectively recorded data of TLLR performed from October 2008 to February 2012 by a single hepato-pancreato-biliary (HPB) surgeon. Patients were divided into two groups according to age (<70 vs. ≥70 years old) and perioperative outcomes were compared. A total of 60 TLLR for malignancies were identified of which 25 patients (42 %) were aged ≥…

AdultMalemedicine.medical_specialtyBlood transfusionCarcinoma HepatocellularCritical Caremedicine.medical_treatmentOperative TimePostoperative ComplicationsmedicineHepatectomyHumansLiver neoplasmProspective StudiesProspective cohort studyAgedRetrospective StudiesAged 80 and overbusiness.industryMortality rateLiver NeoplasmsRetrospective cohort studyPerioperativeLength of StayMiddle AgedLAPAROSCOPIC LIVER RESECTIONS METASTATIC CANCERSurgeryTreatment OutcomeSurgeryFemaleLaparoscopyHepatectomyNeoplasm Recurrence LocalbusinessAbdominal surgerySurgical endoscopy
researchProduct

Long-term follow-up (42 months) of chronic anal fissure after healing with botulinum toxin.

2002

Abstract Background & Aims: Botulinum toxin is an effective treatment in idiopathic chronic anal fissure, but the long-term outcome after healing is not well documented. We analyzed the long-term outcome of patients in whom an anal fissure had healed after botulinum toxin injection and the factors contributing to recurrence. Methods: Fifty-seven patients who had completely healed 6 months after injection of botulinum toxin were reassessed every 6 months. The follow-up was 42 months in all patients. Clinical and manometric differences between the permanently healed and the relapsed group were statistically analyzed. Results: Four patients were lost to follow-up. A fissure recurrence was show…

AdultMalemedicine.medical_specialtyBotulinum ToxinsLong term follow upmedicine.medical_treatmentChronic anal fissureInjectionsRecurrenceLate RecurrencemedicinePressureEffective treatmentHumansAgedAnal fissureChemotherapyWound HealingHepatologyDose-Response Relationship Drugbusiness.industryGastroenterologyMiddle Agedmedicine.diseaseBotulinum toxinSurgeryTotal doseChronic DiseaseRetreatmentFemaleFissure in Anobusinessmedicine.drugFollow-Up StudiesGastroenterology
researchProduct

Five-Year Survival After Monotherapy for Hepatocellular Carcinoma in the Setting of Cirrhosis

2008

The purpose of this study was to evaluate the long-term results with monotherapy for hepatocellular carcinoma (HCC) in the setting of cirrhosis. We reviewed data of 14 patients who survived for at least 5 years after performance of liver resection (n = 1), transarterial chemoembolization (TACE, n = 3), or liver transplantation (OLT, n = 19). Eight patients were within the Milan criteria, whereas the remaining 6 were beyond the criteria. Tumor stages according to the UICC were I (n = 8), II (n = 5), and IIIA (n = 1). Vascular invasion was not detected in any patient. The HCCs recurred in 2 patients, at 81 and 48 months' posttransplant. Sites of recurrence were the intrathoracic lymph nodes i…

AdultMalemedicine.medical_specialtyCarcinoma HepatocellularTime FactorsCirrhosismedicine.medical_treatmentMedizinMilan criteriaLiver transplantationGastroenterologyInternal medicinemedicineCarcinomaHumansSurvivorsChemoembolization TherapeuticSurvival rateAgedTransplantationbusiness.industryLiver NeoplasmsMiddle Agedmedicine.diseaseLiver TransplantationSurgerySurvival RateTransplantationHepatocellular carcinomaFemaleSurgeryalpha-FetoproteinsNeoplasm Recurrence LocalbusinessLiver cancerFollow-Up StudiesTransplantation Proceedings
researchProduct

Liver transplantation for hepatocellular carcinoma--is there a risk of recurrence caused by intraoperative blood salvage autotransfusion?

2011

&lt;i&gt;Background/Aims:&lt;/i&gt; The use of intraoperative blood salvage autotransfusion (IBSA) during surgical approaches may contribute to tumour cell dissemination. Therefore, IBSA should be avoided in cases of malignancy. However, the risks of IBSA might be acceptable in liver transplantation (LT) for selected small hepatocellular carcinoma (HCC). &lt;i&gt;Methods:&lt;/i&gt; In total, 136 recipients of LT with histologically proven HCC in the explanted liver were included in this analysis. With regard to tumour recurrence, 40 patients receiving IBSA despite HCC (IBSA group) were compared to 96 patients without IBSA (non-IBSA group). &lt;i&gt;Results:&lt;/i&gt; Milan criteria as asses…

AdultMalemedicine.medical_specialtyCarcinoma Hepatocellularmedicine.medical_treatmentLiver transplantationMilan criteriaNeoplasm RecurrenceRisk FactorsmedicineCarcinomaHumansAgedSurgical approachIntraoperative blood salvagebusiness.industryOperative Blood SalvageLiver NeoplasmsMiddle Agedmedicine.diseaseNeoplastic Cells CirculatingSurgeryLiver TransplantationHepatocellular carcinomaSurgeryFemaleRadiologyNeoplasm Recurrence LocalbusinessAutotransfusionEuropean surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes
researchProduct

Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma: a retrospective analysis.

1998

Objective This study compares the results of liver transplantation (LTx) and liver resection (LR) for hepatocellular carcinoma (HCC) to test the widespread hypothesis that LTx is the preferable approach for small HCCs. Summary Background Data With respect to scarcity of donor organs and poor results, LTxs for large HCCs are obsolete. Small HCC transplantations have been reported to result in an excellent survival rate. However, the data of comparative studies are controversial. Methods Patients who were treated curatively by LTx (n = 50) or LR (n = 52) for HCC were included in this retrospective study. Survival and freedom from recurrence were analyzed. Patients were stratified according to…

AdultMalemedicine.medical_specialtyCirrhosisCarcinoma Hepatocellularmedicine.medical_treatmentLiver transplantationGastroenterologyDisease-Free SurvivalResectionText miningInternal medicinemedicineHepatectomyHumansSurvival rateAgedRetrospective Studiesbusiness.industryLiver NeoplasmsRetrospective cohort studyMiddle Agedmedicine.diseaseSurgeryLiver TransplantationTransplantationSurvival RateHepatocellular carcinomaSurgeryFemaleNeoplasm Recurrence LocalbusinessResearch Article
researchProduct

Permanent Stoma After Low Anterior Resection for Rectal Cancer

2010

BACKGROUND AND OBJECTIVES: A low anterior resection procedure for removing a rectal tumor aims to preserve the sphincter and avoid a permanent stoma. Permanent stomas are primarily necessary in cases of poor anorectal function and local recurrence. The aim of this study was to clarify whether anastomosis-related complications and local recurrence influenced the rate of permanent stomas in a long-term follow-up. METHODS: Of 1032 consecutive patients with rectal cancer, 397 were treated by low anterior resection (R0 and R1 resections) between 1985 and 2007 at the Department of General and Abdominal Surgery of the University Hospital, Mainz (Germany). All patient data were collected prospectiv…

AdultMalemedicine.medical_specialtyColorectal cancerAdenocarcinomadigestive systemStatistics NonparametricPostoperative ComplicationsStoma (medicine)Risk FactorsmedicineHumansDigestive System Surgical ProceduresAgedRetrospective StudiesAged 80 and overChi-Square DistributionLow Anterior ResectionRectal NeoplasmsAbdominoperineal resectionbusiness.industryGeneral surgeryAnastomosis SurgicalGastroenterologySurgical StomasCancerGeneral MedicineMiddle Agedmedicine.diseasedigestive system diseasesSurgeryLogistic ModelsTreatment Outcomesurgical procedures operativemedicine.anatomical_structureLymphatic MetastasisSphincterFemaleNeoplasm Recurrence LocalComplicationbusinessAbdominal surgeryDiseases of the Colon &amp; Rectum
researchProduct

Radiofrequency ablation as first-line treatment in patients with early colorectal liver metastases amenable to surgery.

2010

Aiming at avoidance of futile surgery, we have tested whether radiofrequency ablation (RFA) may be used as first-line treatment in patients with colorectal metastases (CRLM) occurring within the first year after colorectal surgery.Surgical resection is the standard treatment in patients with CRLM. Major retrospective analyses have identified the interval between colorectal surgery and the occurrence of CRLM to be of prognostic importance. So far, it is unknown whether survival of the respective patients is hampered if RFA is used as first-line treatment.According to a clinical pathway, we have treated patients with CRLM detected within the first year after colorectal surgery preferentially …

AdultMalemedicine.medical_specialtyColorectal cancerRadiofrequency ablationmedicine.medical_treatmentCatheter ablationlaw.inventionlawmedicineHepatectomyHumansIn patientSurvival analysisAgedRetrospective Studiesbusiness.industryLiver NeoplasmsCancerRetrospective cohort studyLength of StayMiddle Agedmedicine.diseaseSurvival AnalysisSurgeryCatheter AblationDisease ProgressionSurgeryFemaleHepatectomyNeoplasm Recurrence LocalbusinessColorectal NeoplasmsAnnals of surgery
researchProduct

Cryotherapy for liver metastases

2000

Cryotherapy is undergoing a renaissance in the treatment of nonresectable liver tumors. In a prospective case control study we assessed the morbidity, mortality, and efficacy of hepatic cryotherapy for liver metastases. Between January 1996 and September 1999 a total of 54 cryosurgical procedures were performed on 49 patients (median age 66 years, 21 women) with liver metastases. Patient, tumor, and operative details were recorded prospectively. Liver metastases originated from colorectal cancer (n=37), gastric cancer (n=3), renal cell carcinoma (n=2), and other primaries (n=7). Median follow-up was 13 months (1-32). The median number of liver metastases was 3 (range 1-10) with a median dia…

AdultMalemedicine.medical_specialtyColorectal cancermedicine.medical_treatmentCryotherapyCryosurgeryMetastasisStomach NeoplasmsRenal cell carcinomaInternal medicinemedicineHumansProspective StudiesAgedTumor markerbusiness.industryLiver NeoplasmsGastroenterologyCancerCryoablationMiddle AgedHepatologymedicine.diseaseSurgeryTreatment OutcomeCase-Control StudiesFemaleMorbidityNeoplasm Recurrence LocalColorectal NeoplasmsbusinessInternational Journal of Colorectal Disease
researchProduct

Avoidance of Overtreatment of Rectal Cancer by Selective Chemoradiotherapy: Results of the Optimized Surgery and MRI-Based Multimodal Therapy Trial.

2020

Background Neoadjuvant chemoradiotherapy (nCRT) in patients with rectal cancer carries a high risk of adverse effects. The aim of this study was to examine the selective application of nCRT based on patient risk profile, as determined by MRI, to find the optimal range between undertreatment and overtreatment. Study Design In this prospective multicenter observational study, nCRT before total mesorectal excision (TME) was indicated in high-risk patients with involved or threatened mesorectal fascia (≤1 mm), or cT4 or cT3 carcinomas of the lower rectal third. All other patients received primary surgery. Results Of the 1,093 patients, 878 (80.3%) were treated according to the protocol, 526 pat…

AdultMalemedicine.medical_specialtyColorectal cancermedicine.medical_treatmentMedical OveruseDisease-Free Survival03 medical and health sciences0302 clinical medicinemedicineHumansProspective StudiesStage (cooking)Adverse effectPathologicalAgedNeoplasm StagingAged 80 and overProctectomybusiness.industryRectal NeoplasmsCarcinomaRectumMultimodal therapyChemoradiotherapy AdjuvantMiddle Agedmedicine.diseaseTotal mesorectal excisionMagnetic Resonance ImagingNeoadjuvant TherapySurgeryRadiation therapy030220 oncology & carcinogenesisCase-Control StudiesPractice Guidelines as Topic030211 gastroenterology & hepatologySurgeryFemaleNeoplasm Recurrence LocalbusinessChemoradiotherapyFollow-Up StudiesJournal of the American College of Surgeons
researchProduct

Surgical treatment of primary gastrointestinal stromal tumors (GISTs): Management and prognostic role of R1 resections

2020

Abstract Background Surgery represents the best treatment for primary gastrointestinal stromal tumors (GISTs). The aim of this study is to analyse outcomes of surgical management in order to evaluate the influence of microscopically R1 margins on survival and recurrence in patients affected by GISTs. Methods The study reviewed retrospective data from 74 patients surgically treated for primary GISTs without metastasis at diagnosis. Clinical and pathological findings, surgical procedures, information about follow up and outcomes were analyzed. Results Recurrence rate was low and no patients died in the R1 group during the follow up period. The difference in recurrence free survival for patien…

AdultMalemedicine.medical_specialtyGastrointestinal Stromal TumorsPrognosiMetastasisPositive microscopic margins03 medical and health sciences0302 clinical medicineHumansMedicineIn patientGastrointestinal stromal tumors (GISTs)Surgical treatmentPathologicalGISTsAgedRetrospective StudiesAged 80 and overGiSTbusiness.industryMargins of ExcisionGeneral MedicineMiddle AgedSurgical proceduresPrognosismedicine.diseaseSurgeryLog-rank test030220 oncology & carcinogenesisFemale030211 gastroenterology & hepatologySurgeryNeoplasm Recurrence LocalPositive microscopic marginbusinessGISTThe American Journal of Surgery
researchProduct